These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23890762)

  • 1. Poor self-awareness of levodopa-induced dyskinesias in Parkinson's disease: clinical features and mechanisms.
    Pietracupa S; Fasano A; Fabbrini G; Sarchioto M; Bloise M; Latorre A; Altieri M; Bologna M; Berardelli A
    Parkinsonism Relat Disord; 2013 Nov; 19(11):1004-8. PubMed ID: 23890762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Why are some Parkinson disease patients unaware of their dyskinesias?
    Jenkinson PM; Edelstyn NM; Stephens R; Ellis SJ
    Cogn Behav Neurol; 2009 Jun; 22(2):117-21. PubMed ID: 19506428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-unawareness of levodopa induced dyskinesias in patients with Parkinson's disease.
    Amanzio M; Palermo S; Zibetti M; Leotta D; Rosato R; Geminiani G; Lopiano L
    Brain Cogn; 2014 Oct; 90():135-41. PubMed ID: 25058494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life in early Parkinson's disease: impact of dyskinesias and motor fluctuations.
    Marras C; Lang A; Krahn M; Tomlinson G; Naglie G;
    Mov Disord; 2004 Jan; 19(1):22-8. PubMed ID: 14743356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Social and economic cost of L-Dopa-induced dyskinesias in patients with Parkinson's disease].
    Maurel F; Lilliu H; Le Pen C
    Rev Neurol (Paris); 2001 May; 157(5):507-14. PubMed ID: 11438770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levodopa-induced dyskinesias in Parkinson's disease: is sensitization reversible?
    Bejjani BP; Arnulf I; Demeret S; Damier P; Bonnet AM; Houeto JL; Agid Y
    Ann Neurol; 2000 May; 47(5):655-8. PubMed ID: 10805339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L-DOPA-induced dyskinesias, motor fluctuations and health-related quality of life: the COPARK survey.
    Perez-Lloret S; Negre-Pages L; Damier P; Delval A; Derkinderen P; Destée A; Meissner WG; Tison F; Rascol O;
    Eur J Neurol; 2017 Dec; 24(12):1532-1538. PubMed ID: 28940893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levodopa-induced dyskinesias in Parkinson's disease phenomenology and pathophysiology.
    Marconi R; Lefebvre-Caparros D; Bonnet AM; Vidailhet M; Dubois B; Agid Y
    Mov Disord; 1994 Jan; 9(1):2-12. PubMed ID: 8139601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous leg dyskinesia assessment in Parkinson's disease -clinical validity and ecological effect.
    Ramsperger R; Meckler S; Heger T; van Uem J; Hucker S; Braatz U; Graessner H; Berg D; Manoli Y; Serrano JA; Ferreira JJ; Hobert MA; Maetzler W;
    Parkinsonism Relat Disord; 2016 May; 26():41-6. PubMed ID: 26952699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal cortical facilitation and L-dopa-induced dyskinesia in Parkinson's disease.
    Guerra A; Suppa A; D'Onofrio V; Di Stasio F; Asci F; Fabbrini G; Berardelli A
    Brain Stimul; 2019; 12(6):1517-1525. PubMed ID: 31217080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do parkinsonian symptoms and levodopa-induced dyskinesias start in the foot?
    Vidailhet M; Bonnet AM; Marconi R; Gouider-Khouja N; Agid Y
    Neurology; 1994 Sep; 44(9):1613-6. PubMed ID: 7936284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dyskinesias and the subthalamic nucleus.
    Benabid AL; Benazzouz A; Limousin P; Koudsie A; Krack P; Piallat B; Pollak P
    Ann Neurol; 2000 Apr; 47(4 Suppl 1):S189-92. PubMed ID: 10762147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson's disease patients.
    Politis M; Wu K; Loane C; Brooks DJ; Kiferle L; Turkheimer FE; Bain P; Molloy S; Piccini P
    J Clin Invest; 2014 Mar; 124(3):1340-9. PubMed ID: 24531549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New ideas on the origin of L-dopa-induced dyskinesias: age, genes and neural plasticity.
    Linazasoro G
    Trends Pharmacol Sci; 2005 Aug; 26(8):391-7. PubMed ID: 16009432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic-pharmacodynamic modeling of levodopa in patients with advanced Parkinson disease.
    Adamiak U; Kaldonska M; Klodowska-Duda G; Wyska E; Safranow K; Bialecka M; Gawronska-Szklarz B
    Clin Neuropharmacol; 2010 May; 33(3):135-41. PubMed ID: 20216409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing dosing frequency of carbidopa/levodopa: double-blind crossover study comparing twice-daily bilayer formulation of carbidopa/levodopa (IPX054) versus 4 daily doses of standard carbidopa/levodopa in stable Parkinson disease patients.
    Hinson VK; Goetz CG; Leurgans S; Fan W; Nguyen T; Hsu A
    Clin Neuropharmacol; 2009; 32(4):189-92. PubMed ID: 19620848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiology of levodopa-induced dyskinesias in Parkinson's disease: problems with the current model.
    Obeso JA; Rodriguez-Oroz MC; Rodriguez M; DeLong MR; Olanow CW
    Ann Neurol; 2000 Apr; 47(4 Suppl 1):S22-32; discussion S32-4. PubMed ID: 10762129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgery for levodopa-induced dyskinesias.
    Lang AE
    Ann Neurol; 2000 Apr; 47(4 Suppl 1):S193-9; discussion S199-202. PubMed ID: 10762148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study.
    Stocchi F; Rascol O; Destee A; Hattori N; Hauser RA; Lang AE; Poewe W; Stacy M; Tolosa E; Gao H; Nagel J; Merschhemke M; Graf A; Kenney C; Trenkwalder C
    Mov Disord; 2013 Nov; 28(13):1838-46. PubMed ID: 23853029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PET Molecular Imaging Research of Levodopa-Induced Dyskinesias in Parkinson's Disease.
    Pagano G; Yousaf T; Politis M
    Curr Neurol Neurosci Rep; 2017 Oct; 17(11):90. PubMed ID: 28975571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.